NEW YORK (GenomeWeb) – Avera McKennan Hospital today announced it has signed an agreement with Foundation Medicine to partner on cancer genomics.

The hospital's Sioux Falls, S.D.-based Avera Cancer Institute is conducting studies with the molecular diagnostics firm that focus on personalized medicine in oncology and fundamental cancer biology.

Other areas of potential future collaboration include joint research, data sharing and database development, education, and patient support programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.